Tally Health
Tally Health is an Aging Diagnostics & Biomarkers company founded in 2021 and based in New York, United States. It has raised $10M in total funding, most recently a Seed in 2023.
Tally Health is a New York-based consumer biotechnology company co-founded by Harvard aging researcher David Sinclair and venture capitalist Melanie Goldey, who serves as CEO; it was incubated and initially backed by L Catterton. Its flagship TallyAge test estimates epigenetic biological age from an at-home cheek swab, paired with personalized lifestyle guidance and research-backed longevity supplements sold through a membership model. The company raised a $10M seed round led by Forerunner Ventures in 2023. In April 2026 Tally Health was acquired by Infinite Epigenetics (parent of TruDiagnostic) but continues to operate as a standalone consumer brand with Goldey remaining CEO.
One of the most visible consumer on-ramps to biological-age testing, carrying David Sinclair's research brand into a direct-to-consumer membership product.
tallyhealth.com ↗·Aging Diagnostics & Biomarkers·
United States·private 
